Home/Pipeline/EPO-producing Cell Therapy

EPO-producing Cell Therapy

Renal Anemia

PreclinicalActive

Key Facts

Indication

Renal Anemia

Phase

Preclinical

Status

Active

Company

About Rege Nephro

A regenerative medicine company using iPS cell technology to develop novel therapies for kidney diseases.

View full company profile

Therapeutic Areas

Nephrology Rare Disease